Firefly Neuroscience Inc (AIFF)

$7.79 +0.59 (8.19%)
Market Cap 57.21M
Revenue (ttm) 7.98M
Net Income (ttm) -2.03M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -25.44%
Debt to Equity Ratio 0.00
Volume 6,896,500
Avg Vol 10,204,962
Day's Range N/A - N/A
Shares Out 7.95M
Stochastic %K 33%
Beta 3.06
Analysts Strong Buy
Price Target N/A

Latest News on AIFF

Firefly Neuroscience Announces Exercise of Warrants for Total Proceeds of $8.8 Million

Feb 21, 2025, 8:00 AM EST - 1 day ago

Firefly Neuroscience Announces Exercise of Warrants for Total Proceeds of $8.8 Million

Firefly Neuroscience Accepted into NVIDIA Connect Program

Feb 11, 2025, 7:45 AM EST - 11 days ago

Firefly Neuroscience Accepted into NVIDIA Connect Program

Firefly Neuroscience Congratulates Scientific Advisor, Dr. Christopher Wilson, Recipient of Prestigious UW Faculty of Engineering Award for Work on Superconducting Quantum Electronics

Feb 7, 2025, 7:30 AM EST - 15 days ago

Firefly Neuroscience Congratulates Scientific Advisor, Dr. Christopher Wilson, Recipient of Prestigious UW Faculty of Engineering Award for Work on Superconducting Quantum Electronics

Crude Oil Down 1%; Firefly Neuroscience Shares Spike Higher

Jan 14, 2025, 12:25 PM EST - 5 weeks ago

Crude Oil Down 1%; Firefly Neuroscience Shares Spike Higher

Firefly Neuroscience Discovers Breakthrough Cognitive Brain Age Biomarker Using its FDA-Cleared BNA™ Platform

Jan 14, 2025, 7:45 AM EST - 5 weeks ago

Firefly Neuroscience Discovers Breakthrough Cognitive Brain Age Biomarker Using its FDA-Cleared BNA™ Platform

Firefly Neuroscience Closes on Financing of up to $12.4 Million

Dec 31, 2024, 9:00 AM EST - 7 weeks ago

Firefly Neuroscience Closes on Financing of up to $12.4 Million

Firefly Neuroscience Reports Third Quarter 2024 Results and Provides Stockholder Update

Nov 14, 2024, 5:30 PM EST - 3 months ago

Firefly Neuroscience Reports Third Quarter 2024 Results and Provides Stockholder Update

Firefly Neuroscience to Participate in the 8th Annual Florida Capital Event

Nov 6, 2024, 9:00 AM EST - 3 months ago

Firefly Neuroscience to Participate in the 8th Annual Florida Capital Event

Firefly Neuroscience Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Oct 25, 2024, 4:10 PM EDT - 4 months ago

Firefly Neuroscience Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Firefly Neuroscience Collaborates with Bright Minds Biosciences to Analyze the Data from its Positive Phase 1 Study using its Artificial Intelligence, FDA-Cleared BNA™ Technology

Oct 16, 2024, 9:20 AM EDT - 4 months ago

Firefly Neuroscience Collaborates with Bright Minds Biosciences to Analyze the Data from its Positive Phase 1 Study using its Artificial Intelligence, FDA-Cleared BNA™ Technology

Firefly Neuroscience to Participate in Upcoming October Investor Conferences

Oct 11, 2024, 9:00 AM EDT - 4 months ago

Firefly Neuroscience to Participate in Upcoming October Investor Conferences

Firefly Neuroscience Announces Partnership with Zeto to Integrate and Distribute its BNA™ Technology with Zeto's FDA-Cleared EEG Device Platform

Sep 10, 2024, 9:00 AM EDT - 5 months ago

Firefly Neuroscience Announces Partnership with Zeto to Integrate and Distribute its BNA™ Technology with Zeto's FDA-Cleared EEG Device Platform

Firefly Neuroscience CEO Jon Olsen to Present at H.C. Wainwright's 26th Annual Global Investment Conference September 9-11

Aug 26, 2024, 9:00 AM EDT - 6 months ago

Firefly Neuroscience CEO Jon Olsen to Present at H.C. Wainwright's 26th Annual Global Investment Conference September 9-11

Firefly Neuroscience, an AI-Driven Brain Health Company, to Host Shareholder Update Call on September 4th

Aug 22, 2024, 9:00 AM EDT - 6 months ago

Firefly Neuroscience, an AI-Driven Brain Health Company, to Host Shareholder Update Call on September 4th

Firefly Neuroscience Forms Strategic Partnership with Neurology Consultants of Dallas (NCD) to Enhance Early Detection Efforts and Disease Management for Patients with Cognitive Disorders

Aug 21, 2024, 9:00 AM EDT - 6 months ago

Firefly Neuroscience Forms Strategic Partnership with Neurology Consultants of Dallas (NCD) to Enhance Early Detection Efforts and Disease Management for Patients with Cognitive Disorders

UPDATE -- Firefly Neuroscience CEO Issues Letter to Stockholders Following Closing of Merger and Listing on Nasdaq

Aug 13, 2024, 4:06 PM EDT - 6 months ago

UPDATE -- Firefly Neuroscience CEO Issues Letter to Stockholders Following Closing of Merger and Listing on Nasdaq